Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy
about
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsExploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologiesDevelopment of HIF-1 inhibitors for cancer therapyOvercoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression.Comparison of effects of anti-angiogenic agents in the zebrafish efficacy-toxicity model for translational anti-angiogenic drug discovery.Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signalingTargeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factorDevelopment of novel therapeutic strategies that target HIF-1.The role of hypoxia inducible factor-1 in cell metabolism--a possible target in cancer therapy.Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell linesBack to basics: how natural products can provide the basis for new therapeutics.Targeting the hypoxia-inducible factor (HIF) pathway in cancer.Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapyModulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.Recent agents targeting HIF-1α for cancer therapy.Malignant glioma drug discovery - targeting protein kinases.Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.Potential Use of Flavopiridol in Treatment of Chronic Diseases.Antiproliferative and antiangiogenic properties of horse chestnut extract.Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and TherapiesER-α agonist induces conversion of fibroblasts into myofibroblasts, while ER-β agonist increases ECM production and wound tensile strength of healing skin wounds in ovariectomised rats.HIF-1 inhibitors as anti-cancer therapy
P2860
Q24631327-461A8471-1AA5-4555-B730-68ECB954889CQ27701444-9427CE17-7672-4A17-AFB9-541924EF2796Q33703381-3C9CEC24-735B-4D41-B535-6BBCAB0A0120Q33925043-1F04691E-3BD1-4314-B84D-F2F551E08E7CQ34060715-5D59563D-8D34-4CD3-B6C9-1246D8CE08BFQ34094154-B20E064F-53C7-4D1B-847A-FFBB4725BDA6Q34753820-DFD0DBF1-352F-4B9C-81A5-EF85BE868F0FQ35759208-41FAC940-8EF4-4456-B2B4-13AAE4E24CC2Q35812724-ED9DD4FC-E116-4C7F-B2DD-A431FA532650Q36425968-FBBF2504-A97D-40E9-A72F-F35A65491C98Q36539483-7F38287E-11B5-4486-8131-A2D7EFFC6AC6Q36541660-1A372683-A22B-4239-9C49-19647084AEBBQ36985862-7E2AD094-908A-482B-9D4C-FD603C023440Q37587446-D8368429-ECC4-4814-9418-5DBD009B363EQ37734481-4627A133-8E2F-4C6D-856F-605AE0D2C6CBQ37943792-E4DA228E-E530-49A9-B713-E2B0E662177BQ38042021-3CF2FDA2-4F33-4576-B6C6-FFBD132CBDAEQ38089834-9067841F-7D70-4267-B5DA-FD4AC00F1FB5Q38108833-351F2BB0-FBB0-4846-97C5-B49FF5FEC2BEQ38988581-D5A3412A-F1B8-4CC9-9EE7-E5902D3AD54BQ39373374-89C33715-4F98-443C-9235-7D5D9806425AQ42426199-5B816DAB-85DE-45DA-8299-F0F9D1250C08Q53252890-3F344CD7-0F92-469D-820C-FFC530DD95A3Q57696989-D7FC7AFC-28EE-4A4B-BA2A-19FC1C64C5E3
P2860
Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Flavopiridol downregulates hyp ...... plications for in vivo therapy
@ast
Flavopiridol downregulates hyp ...... plications for in vivo therapy
@en
type
label
Flavopiridol downregulates hyp ...... plications for in vivo therapy
@ast
Flavopiridol downregulates hyp ...... plications for in vivo therapy
@en
prefLabel
Flavopiridol downregulates hyp ...... plications for in vivo therapy
@ast
Flavopiridol downregulates hyp ...... plications for in vivo therapy
@en
P2093
P2860
P1433
P1476
Flavopiridol downregulates hyp ...... plications for in vivo therapy
@en
P2093
David Zagzag
Douglas C Miller
Elizabeth W Newcomb
M Aktar Ali
Mary Fowkes
Tona Schnee
Yevgeniy Lukyanov
P2860
P304
P356
10.1215/S1152851704000997
P577
2005-07-01T00:00:00Z